Melanie E. Fields
Washington University in St. Louis
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Melanie E. Fields.
Blood | 2015
Kristin Guilliams; Melanie E. Fields; Monica L. Hulbert
To the editor: Individuals with hemoglobin (Hb) SC disease have fewer vaso-occlusive events and greater life expectancy than those with Hb SS, and they have been excluded from most interventional clinical trials. Although the 10% prevalence of overt stroke and >35% prevalence of silent cerebral
Transfusion | 2015
Melanie E. Fields; Monica L. Hulbert; Ling Chen; Ari N. Berlin; Ron Jackups; Philip C. Spinella
Providers commonly transfuse sickle cell disease (SCD) patients with fresh red blood cells (RBCs) as treatment for acute chest syndrome (ACS). The objective of this study was to determine if there is an association between the storage duration of RBCs and length of hospitalization and oxygen requirement after transfusion in pediatric SCD patients with ACS.
Neurology | 2018
Melanie E. Fields; Kristin Guilliams; Dustin K. Ragan; Michael M. Binkley; Cihat Eldeniz; Yasheng Chen; Monica L. Hulbert; Robert C. McKinstry; Joshua S. Shimony; Katie D. Vo; Allan Doctor; Hongyu An; Andria L. Ford; Jin-Moo Lee
Objective To determine mechanisms underlying regional vulnerability to infarction in sickle cell disease (SCD) by measuring voxel-wise cerebral blood flow (CBF), oxygen extraction fraction (OEF), and cerebral metabolic rate of oxygen utilization (CMRO2) in children with SCD. Methods Participants underwent brain MRIs to measure voxel-based CBF, OEF, and CMRO2. An infarct heat map was created from an independent pediatric SCD cohort with silent infarcts and compared to prospectively obtained OEF maps. Results Fifty-six participants, 36 children with SCD and 20 controls, completed the study evaluation. Whole-brain CBF (99.2 vs 66.3 mL/100 g/min, p < 0.001), OEF (42.7% vs 28.8%, p < 0.001), and CMRO2 (3.7 vs 2.5 mL/100 g/min, p < 0.001) were higher in the SCD cohort compared to controls. A region of peak OEF was identified in the deep white matter in the SCD cohort, delineated by a ratio map of average SCD to control OEF voxels. CMRO2 in this region, which encompassed the CBF nadir, was low relative to all white matter (p < 0.001). Furthermore, this peak OEF region colocalized with regions of greatest infarct density derived from an independent SCD cohort. Conclusions Elevated OEF in the deep white matter identifies a signature of metabolically stressed brain tissue at increased stroke risk in pediatric patients with SCD. We propose that border zone physiology, exacerbated by chronic anemic hypoxia, explains the high risk in this region.
Blood | 2017
Kristin Guilliams; Melanie E. Fields; Dustin K. Ragan; Cihat Eldeniz; Michael M. Binkley; Yasheng Chen; Liam S. Comiskey; Allan Doctor; Monica L. Hulbert; Joshua S. Shimony; Katie D. Vo; Robert C. McKinstry; Hongyu An; Jin-Moo Lee; Andria L. Ford
Blood transfusions are the mainstay of stroke prevention in pediatric sickle cell anemia (SCA), but the physiology conferring this benefit is unclear. Cerebral blood flow (CBF) and oxygen extraction fraction (OEF) are elevated in SCA, likely compensating for reduced arterial oxygen content (CaO2). We hypothesized that exchange transfusions would decrease CBF and OEF by increasing CaO2, thereby relieving cerebral oxygen metabolic stress. Twenty-one children with SCA receiving chronic transfusion therapy (CTT) underwent magnetic resonance imaging before and after exchange transfusions. Arterial spin labeling and asymmetric spin echo sequences measured CBF and OEF, respectively, which were compared pre- and posttransfusion. Volumes of tissue with OEF above successive thresholds (36%, 38%, and 40%), as a metric of regional metabolic stress, were compared pre- and posttransfusion. Transfusions increased hemoglobin (Hb; from 9.1 to 10.3 g/dL; P < .001) and decreased Hb S (from 39.7% to 24.3%; P < .001). Transfusions reduced CBF (from 88 to 82.4 mL/100 g per minute; P = .004) and OEF (from 34.4% to 31.2%; P < .001). At all thresholds, transfusions reduced the volume of peak OEF found in the deep white matter, a location at high infarct risk in SCA (P < .001). Reduction of elevated CBF and OEF, both globally and regionally, suggests that CTT mitigates infarct risk in pediatric SCA by relieving cerebral metabolic stress at patient- and tissue-specific levels.
Pediatric Blood & Cancer | 2016
Melanie E. Fields; Catherine Hoyt‐Drazen; Regina Abel; Mark Rodeghier; Janet Yarboi; Bruce E. Compas; Allison King
Young children with sickle cell disease (SCD) are at risk for cognitive delay. In addition to biologic risk factors associated with SCD, environmental factors contribute to cognitive dysfunction within this cohort.
Blood | 2018
Andria L. Ford; Dustin K. Ragan; Slim Fellah; Michael M. Binkley; Melanie E. Fields; Kristin Guilliams; Hongyu An; Lori C. Jordan; Robert C. McKinstry; Jin-Moo Lee; Michael R. DeBaun
Silent cerebral infarcts (SCIs) are associated with cognitive impairment in sickle cell anemia (SCA). SCI risk factors include low hemoglobin and elevated systolic blood pressure; however, mechanisms underlying their development are unclear. Using the largest prospective study evaluating SCIs in pediatric SCA, we identified brain regions with increased SCI density. We tested the hypothesis that infarct density is greatest within regions in which cerebral blood flow is lowest, further restricting cerebral oxygen delivery in the setting of chronic anemia. Neuroradiology and neurology committees reached a consensus of SCIs in 286 children in the Silent Infarct Transfusion (SIT) Trial. Each infarct was outlined and coregistered to a brain atlas to create an infarct density map. To evaluate cerebral blood flow as a function of infarct density, pseudocontinuous arterial spin labeling was performed in an independent pediatric SCA cohort. Blood flow maps were aligned to the SIT Trial infarct density map. Mean blood flow within low, moderate, and high infarct density regions from the SIT Trial were compared. Logistic regression evaluated clinical and imaging predictors of overt stroke at 3-year follow-up. The SIT Trial infarct density map revealed increased SCI density in the deep white matter of the frontal and parietal lobes. A relatively small region, measuring 5.6% of brain volume, encompassed SCIs from 90% of children. Cerebral blood flow was lowest in the region of highest infarct density (P < .001). Baseline infarct volume and reticulocyte count predicted overt stroke. In pediatric SCA, SCIs are symmetrically located in the deep white matter where minimum cerebral blood flow occurs.
Pediatric Neurology | 2017
Kristin Guilliams; Melanie E. Fields; Dustin K. Ragan; Yasheng Chen; Cihat Eldeniz; Monica L. Hulbert; Michael M. Binkley; James N. Rhodes; Joshua S. Shimony; Robert C. McKinstry; Katie D. Vo; Hongyu An; Jin-Moo Lee; Andria L. Ford
Blood | 2015
Melanie E. Fields; Regina Abel; Sara K. Vesely; Catherine Hoyt Drazen; Allison King
Blood | 2014
Debbie Woods; Robert J. Hayashi; Melanie E. Fields; Monica L. Hulbert
Stroke | 2018
Andria L. Ford; Kristin Guilliams; Melanie E. Fields; Dustin K. Ragan; Slim Fellah; Cihat Eldeniz; Michael M. Binkley; Yasheng Chen; Josh Shimony; Katie Vo; Morey A. Blinder; Monica L. Hulbert; Robert C. McKinstry; Hongyu An; Jin-Moo Lee